Treatment of late Lyme borreliosis with cefoperazone and sulbactam

Lancet. 1995 Mar 4;345(8949):586. doi: 10.1016/s0140-6736(95)90496-4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Borrelia burgdorferi Group / immunology
  • Cefoperazone / therapeutic use*
  • Drug Therapy, Combination / therapeutic use*
  • Humans
  • Immunoglobulin G / immunology
  • Lyme Disease / drug therapy*
  • Lyme Disease / immunology
  • Male
  • Sulbactam / therapeutic use*
  • beta-Lactam Resistance

Substances

  • Immunoglobulin G
  • Cefoperazone
  • Sulbactam